Drug Database
Back to search

Belgium· BE-AMP-SAM273034-00

Wilzin 25 mg

A zinc acetate product containing zinc, registered in Belgium by Recordati Rare Diseases. The same ATC class is registered in 9 of our 19 countries.

ATC A16AX05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedWilzin 25 mgATCA16AX05REGISTER NO.BE-AMP-SAM273034-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zincAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zinc acetate is registered in 9 of 19 countries.

Countries holding a registration under ATC A16AX05 (zinc acetate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search zinc acetate products by name

Zinc acetate · ATC A16AX05

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Zinc
Manufacturer
Recordati Rare Diseases
Country
Belgium (BE)
ATC code
A16AX05
ATC class
Zinc acetate
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2211423

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

124 interactions on record for zinc acetate.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zinc acetate against other medicinesHow interaction checks work

Zinc acetate · interactions on record

124 records

  • 4 severe
  • 31 moderate
  • 89 minor

Most severe, free to view

  • RaltegravirJ05AJ01severe
  • ElvitegravirJ05AJ02severe
  • RaltegravirJ05AX08severe
  • ElvitegravirJ05AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zinc acetate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zinc acetate products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Labisan, Zink Aguettant
  • Germany · Biolectra, Cefazink
  • Denmark · Zipzoc
  • Spain · Pasta Lassar Imba
  • Finland · Zipzoc
  • France · Effizinc, Oligosol
  • United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
  • Greece · Zincalto, Zinctin
  • Ireland · Caldease, Zinc Ovelle
  • Iceland · Wilzin
  • Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
  • Liechtenstein · Wilzin
  • Luxembourg · Cefazink, Oligosol
  • Latvia · Cinka Rff
  • Netherlands · Daro Zinkzalf, Zinkolie
  • Norway · Wilzin
  • Poland · Maść Cynkowa,, Maść Z Tlenkiem Cynku
  • Portugal · Halibut, Lassadermil
  • Sweden · Zipzoc
  • Slovakia · Tekutý Púder

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7d5b00a6-e1a3-428b-8654-35f96a3c1f70
GET /v1/drugs/7d5b00a6-e1a3-428b-8654-35f96a3c1f70?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Wilzin 25 mg",
  "name_fr": "Wilzin 25 mg",
  "name_nl": "Wilzin 25 mg",
  "amp_code": "SAM273034-00",
  "strengths": [
    "83.9200",
    "83.9200"
  ],
  "pack_count": 1,
  "substances": [
    "Zinc"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Zinc Acetate",
  "authorisation_numbers": [
    "EU/1/04/286/001"
  ]
}
API referenceMCP serverPlans

See everything about zinc acetate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console